Dr Yen Choo is one of biotechnology’s brightest stars. And in Progenitor, his third venture, the much-lauded scientist has proved that he’s no novice when it comes to business, either. The proof…
Crossject
It has been a long path for Patrick Alexandre and Crossject, but 2014 looks like being the company’s annus mirabilis. A successful public offering, product development and funding round: enough to make…